StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1409.38−1.61 (-0.11%)

Close on Nov 3, 2026Market cap $1.33TP/E 45.7Yield 0.44%

Eli Lilly Alimta (pemetrexed) by Quarter

Alimta (pemetrexed) — Worldwide revenue YoY (%) [legacy] (%)

QuarterlyAnnual

Eli Lilly Alimta (pemetrexed): -81.0% in Q4 2023, down 35.0 pts from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2023
-81.0%
Period ended Dec 31, 2023
Change on a year earlier
-35.0 pts
-46.0% in Q4 2022
History
22 quarters
Since Q1 2018
Sources
22
Documents cited below

Where the Q4 2023 figure comes from

“|| Alimta | 44.9 | 236.6 | (81)% | 217.5 | 927.7 | (77)%”

Source: Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAlimta (pemetrexed) — Worldwide revenue YoY (%) [legacy] (%)Year on yearSource
Q4 2023Dec 31, 2023-81.0%-35.0 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 2023-55.0%+19.0 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 2023-73.0%-10.0 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 2023-83.0%-45.0 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022-46.0%-13.0 ptsEarnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 2022-74.0%-53.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗
Q2 2022Jun 30, 2022-63.0%-76.0 ptsForm 10-Q FY2022Q2 (filed 2022-08-04) ↗
Q1 2022Mar 31, 2022-38.0%-38.0 ptsForm 10-Q FY2022Q1 (filed 2022-04-29) ↗
Q4 2021Dec 31, 2021-33.0%-56.0 ptsEarnings Release (Form 8-K FY2021Q4 EX-99.1) (filed 2022-02-03) ↗
Q3 2021Sep 30, 2021-21.0%-35.0 ptsForm 10-Q FY2021Q3 (filed 2021-10-27) ↗
Q2 2021Jun 30, 202113.0%+20.0 ptsForm 10-Q FY2021Q2 (filed 2021-08-03) ↗
Q1 2021Mar 31, 2021-0.0%-12.0 ptsEarnings Release (Form 8-K FY2021Q1 EX-99.1) (filed 2021-04-27) ↗
Q4 2020Dec 31, 202023.0%–Earnings Release (Form 8-K FY2020Q4 EX-99.1) (filed 2021-01-29) ↗
Q3 2020Sep 30, 202014.0%+16.0 ptsForm 10-Q FY2020Q3 (filed 2020-10-28) ↗
Q2 2020Jun 30, 2020-7.0%-11.0 ptsForm 10-Q FY2020Q2 (filed 2020-07-31) ↗
Q1 2020Mar 31, 202012.0%+12.0 ptsForm 10-Q FY2020Q1 (filed 2020-05-01) ↗

Cite this data

StockData. (2026). Eli Lilly Alimta (pemetrexed) (%), quarterly Q1 2018–Q4 2023 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-alimta-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.

See a number that looks wrong?